Literature DB >> 17878527

Drug transporters as targets for cancer chemotherapy.

Takeo Nakanishi1.   

Abstract

Transporter proteins play an important role in taking up nutrients into and effluxing xenobiotics out of cells to sustain cell survival. Transporters that affect drug absorption, distribution and excretion are the so-called drug transporters. In the last decade, a number of studies revealed interactions between drug transporters and clinically important anticancer agents. Utilizing the knowledge of transporter functions offers us the possibility of delivering a drug to the target tissues, avoiding distribution to other tissues and improving oral bioavailability. Many transporters have been reported to be differentially up-regulated in cancer cells compared to normal tissues, suggesting that the differential expression of transporters in cancer cells may provide good targets for enhancing drug delivery as well as diagnostic markers for cancer therapy. This review will focus on the role of drug transporters in the adaptation and growth of tumors and in their potential usefulness as therapeutic targets in cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17878527

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  17 in total

Review 1.  Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions.

Authors:  Robert Gharavi; William Hedrich; Hongbing Wang; Hazem E Hassan
Journal:  Pharm Res       Date:  2015-05-14       Impact factor: 4.200

2.  In silico analysis of SLC3A1 and SLC7A9 mutations in Iranian patients with Cystinuria.

Authors:  Manijeh Mahdavi; Leila Koulivand; Mehdi Khorrami; Maryam Mirsafaie; Majid Kheirollahi
Journal:  Mol Biol Rep       Date:  2018-08-01       Impact factor: 2.316

3.  Expression of Genes Involved in Porphyrin Biosynthesis Pathway in the Human Renal Cell Carcinoma.

Authors:  Hugo Nóbrega da Rocha Filho; Evelin Caroline da Silva; Flávia R O Silva; Lilia Coronato Courrol; Carlos Henrique de Mesquita; Maria Helena Bellini
Journal:  J Fluoresc       Date:  2015-08-06       Impact factor: 2.217

4.  Silencing of Taxol-Sensitizer Genes in Cancer Cells: Lack of Sensitization Effects.

Authors:  Shang-Lang Huang; Chuck C-K Chao
Journal:  Cancers (Basel)       Date:  2015-06-16       Impact factor: 6.639

5.  Integrative transcriptomics-based identification of cryptic drivers of taxol-resistance genes in ovarian carcinoma cells: Analysis of the androgen receptor.

Authors:  Nian-Kang Sun; Shang-Lang Huang; Hsing-Pang Lu; Ting-Chang Chang; Chuck C-K Chao
Journal:  Oncotarget       Date:  2015-09-29

Review 6.  Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.

Authors:  Takeo Nakanishi; Douglas D Ross
Journal:  Chin J Cancer       Date:  2011-11-18

7.  Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy.

Authors:  Limin Huang; Christelle Perrault; Jennifer Coelho-Martins; Chaoquan Hu; Charlène Dulong; Mariana Varna; Jielin Liu; Jian Jin; Claudine Soria; Lionel Cazin; Anne Janin; Hong Li; Rémi Varin; He Lu
Journal:  J Hematol Oncol       Date:  2013-07-09       Impact factor: 17.388

8.  Transcriptomic profiling of taxol-resistant ovarian cancer cells identifies FKBP5 and the androgen receptor as critical markers of chemotherapeutic response.

Authors:  Nian-Kang Sun; Shang-Lang Huang; Pu-Yuan Chang; Hsing-Pang Lu; Chuck C-K Chao
Journal:  Oncotarget       Date:  2014-12-15

9.  Studies on the anti-angiogenic effect of Marsdenia tenacissima extract in vitro and in vivo.

Authors:  Zhengrong Huang; Hao Lin; Yong Wang; Zhiyun Cao; Wei Lin; Qiang Chen
Journal:  Oncol Lett       Date:  2013-01-04       Impact factor: 2.967

10.  Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types.

Authors:  Craig P Giacomini; Steven Sun; Sushama Varma; A Hunter Shain; Marilyn M Giacomini; Jay Balagtas; Robert T Sweeney; Everett Lai; Catherine A Del Vecchio; Andrew D Forster; Nicole Clarke; Kelli D Montgomery; Shirley Zhu; Albert J Wong; Matt van de Rijn; Robert B West; Jonathan R Pollack
Journal:  PLoS Genet       Date:  2013-04-25       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.